Modulation of innate and adaptive immunity by cytomegaloviruses

[1]  Y. Li,et al.  A new checkpoint receptor targets for cancer immunotherapy , 2020, The Journal of Immunology.

[2]  C. Leslie,et al.  Mouse cytomegalovirus-experienced ILC1s acquire a memory response dependent on the viral glycoprotein m12 , 2019, Nature Immunology.

[3]  J. Rossjohn,et al.  Structural basis for the recognition of nectin-like protein-5 by the human-activating immune receptor, DNAM-1 , 2019, The Journal of Biological Chemistry.

[4]  S. Jonjić,et al.  The complex of MCMV proteins and MHC class I evades NK cell control and drives the evolution of virus-specific activating Ly49 receptors , 2019, The Journal of experimental medicine.

[5]  F. Baldanti,et al.  Human Cytomegalovirus Genomes Sequenced Directly From Clinical Material: Variation, Multiple-Strain Infection, Recombination, and Gene Loss , 2019, The Journal of infectious diseases.

[6]  Domènec Farré,et al.  Subversion of natural killer cell responses by a cytomegalovirus-encoded soluble CD48 decoy receptor , 2019, PLoS pathogens.

[7]  Asif U. Tamuri,et al.  Human cytomegalovirus haplotype reconstruction reveals high diversity due to superinfection and evidence of within-host recombination , 2019, Proceedings of the National Academy of Sciences.

[8]  J. Rossjohn,et al.  Structural Basis for CD96 Immune Receptor Recognition of Nectin-like Protein-5, CD155. , 2019, Structure.

[9]  J. P. Martins,et al.  Strain-specific antibody therapy prevents cytomegalovirus reactivation after transplantation , 2019, Science.

[10]  M. Reddehase,et al.  Mouse Model of Cytomegalovirus Disease and Immunotherapy in the Immunocompromised Host: Predictions for Medical Translation that Survived the “Test of Time” , 2018, Viruses.

[11]  L. Picker,et al.  Identification and Functional Characterization of a Novel Fc Gamma-Binding Glycoprotein in Rhesus Cytomegalovirus , 2018, Journal of Virology.

[12]  J. Munger,et al.  Who’s Driving? Human Cytomegalovirus, Interferon, and NFκB Signaling , 2018, Viruses.

[13]  L. Dassa,et al.  The Human Cytomegalovirus Protein UL148A Downregulates the NK Cell-Activating Ligand MICA To Avoid NK Cell Attack , 2018, Journal of Virology.

[14]  S. Springer,et al.  Cytomegalovirus gp40/m152 Uses TMED10 as ER Anchor to Retain MHC Class I. , 2018, Cell reports.

[15]  J. Moffat,et al.  The Inhibitory NKR-P1B:Clr-b Recognition Axis Facilitates Detection of Oncogenic Transformation and Cancer Immunosurveillance. , 2018, Cancer research.

[16]  H. Favoreel,et al.  Herpesvirus Evasion of Natural Killer Cells , 2018, Journal of Virology.

[17]  I. Weissman,et al.  Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy , 2017, Nature Immunology.

[18]  O. Mandelboim,et al.  Human cytomegalovirus escapes immune recognition by NK cells through the downregulation of B7-H6 by the viral genes US18 and US20 , 2017, Scientific Reports.

[19]  F. Momburg,et al.  A highly conserved sequence of the viral TAP inhibitor ICP47 is required for freezing of the peptide transport cycle , 2017, Scientific Reports.

[20]  P. Moss,et al.  A disease-linked ULBP6 polymorphism inhibits NKG2D-mediated target cell killing by enhancing the stability of NKG2D ligand binding , 2017, Science Signaling.

[21]  J. Rossjohn,et al.  Recognition of nectin-2 by the natural killer cell receptor T cell immunoglobulin and ITIM domain (TIGIT) , 2017, The Journal of Biological Chemistry.

[22]  S. Jonjić,et al.  A Viral Immunoevasin Controls Innate Immunity by Targeting the Prototypical Natural Killer Cell Receptor Family , 2017, Cell.

[23]  W. Dougall,et al.  TIGIT and CD96: new checkpoint receptor targets for cancer immunotherapy , 2017, Immunological reviews.

[24]  S. Gygi,et al.  Control of immune ligands by members of a cytomegalovirus gene expansion suppresses natural killer cell activation , 2017, eLife.

[25]  Nikolaus Grigorieff,et al.  Structure of the transporter associated with antigen processing trapped by herpes simplex virus , 2016, eLife.

[26]  A. Santoni,et al.  Distinct Roles for Human Cytomegalovirus Immediate Early Proteins IE1 and IE2 in the Transcriptional Regulation of MICA and PVR/CD155 Expression , 2016, The Journal of Immunology.

[27]  S. Jonjić,et al.  Inflammatory monocytes and NK cells play a crucial role in DNAM-1–dependent control of cytomegalovirus infection , 2016, The Journal of experimental medicine.

[28]  R. Brennan,et al.  Coinfection with Human Cytomegalovirus Genetic Variants in Transplant Recipients and Its Impact on Antiviral T Cell Immune Reconstitution , 2016, Journal of Virology.

[29]  P. Tomasec,et al.  Genetic Stability of Bacterial Artificial Chromosome-Derived Human Cytomegalovirus during Culture In Vitro , 2016, Journal of Virology.

[30]  L. Lanier,et al.  Natural killer cell memory in infection, inflammation and cancer , 2016, Nature Reviews Immunology.

[31]  S. Fraser,et al.  Characterization of Antibody Bipolar Bridging Mediated by the Human Cytomegalovirus Fc Receptor gp68 , 2016, Journal of Virology.

[32]  M. Furione,et al.  Reconstitution of Human Cytomegalovirus-Specific CD4+ T Cells is Critical for Control of Virus Reactivation in Hematopoietic Stem Cell Transplant Recipients but Does Not Prevent Organ Infection. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[33]  Bjoern Peters,et al.  Cytomegalovirus-Specific CD4 T Cells Are Cytolytic and Mediate Vaccine Protection , 2015, Journal of Virology.

[34]  J. Rossjohn,et al.  A bird's eye view of NK cell receptor interactions with their MHC class I ligands , 2015, Immunological reviews.

[35]  L. Lanier.  NKG2D Receptor and Its Ligands in Host Defense , 2015, Cancer Immunology Research.

[36]  Peter Chen,et al.  Modulation of Clr Ligand Expression and NKR-P1 Receptor Function during Murine Cytomegalovirus Infection , 2015, Journal of Innate Immunity.

[37]  M. Weekes,et al.  Human cytomegalovirus: taking the strain , 2015, Medical Microbiology and Immunology.

[38]  James McCluskey,et al.  T cell antigen receptor recognition of antigen-presenting molecules. , 2015, Annual review of immunology.

[39]  M. Weekes,et al.  Plasma Membrane Profiling Defines an Expanded Class of Cell Surface Proteins Selectively Targeted for Degradation by HCMV US2 in Cooperation with UL141 , 2015, PLoS pathogens.

[40]  E. Wiertz,et al.  Viral immune evasion: Lessons in MHC class I antigen presentation. , 2015, Seminars in immunology.

[41]  O. Mandelboim,et al.  Dynamic Co-evolution of Host and Pathogen: HCMV Downregulates the Prevalent Allele MICA*008 to Escape Elimination by NK Cells , 2015, Cell reports.

[42]  A. Cerwenka,et al.  IL-12-producing monocytes and HLA-E control HCMV-driven NKG2C+ NK cell expansion. , 2014, The Journal of clinical investigation.

[43]  A. Bax,et al.  The structure of mouse cytomegalovirus m04 protein obtained from sparse NMR data reveals a conserved fold of the m02-m06 viral immune modulator family. , 2014, Structure.

[44]  M. Furione,et al.  Human Cytomegalovirus (HCMV)-Specific CD4+ and CD8+ T Cells Are Both Required for Prevention of HCMV Disease in Seropositive Solid-Organ Transplant Recipients , 2014, PloS one.

[45]  J. Rossjohn,et al.  The Structure of the Cytomegalovirus-Encoded m04 Glycoprotein, a Prototypical Member of the m02 Family of Immunoevasins* , 2014, The Journal of Biological Chemistry.

[46]  A. Moosmann,et al.  CD8 T Cell–Evasive Functions of Human Cytomegalovirus Display Pervasive MHC Allele Specificity, Complementarity, and Cooperativity , 2014, The Journal of Immunology.

[47]  F. Souza-Fonseca-Guimaraes,et al.  The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions , 2014, Nature Immunology.

[48]  M. Weekes,et al.  Two Novel Human Cytomegalovirus NK Cell Evasion Functions Target MICA for Lysosomal Degradation , 2014, PLoS pathogens.

[49]  É. Vivier,et al.  Natural cytotoxicity receptors and their ligands , 2014, Immunology and cell biology.

[50]  Domènec Farré,et al.  Cytomegalovirus m154 Hinders CD48 Cell-Surface Expression and Promotes Viral Escape from Host Natural Killer Cell Control , 2014, PLoS pathogens.

[51]  Sachithra Hemachandra,et al.  KIR and HLA Interactions Are Associated With Control of Primary CMV Infection in Solid Organ Transplant Recipients , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[52]  C. Ahn,et al.  Human cytomegalovirus (HCMV) US2 protein interacts with human CD1d (hCD1d) and down-regulates invariant NKT (iNKT) cell activity , 2013, Molecules and cells.

[53]  A. Oxenius,et al.  Adoptive transfer of cytomegalovirus‐specific effector CD4+ T cells provides antiviral protection from murine CMV infection , 2013, European journal of immunology.

[54]  J. Orange.  Natural killer cell deficiency. , 2013, Journal of Allergy and Clinical Immunology.

[55]  H. Reyburn,et al.  A GPI anchor explains the unique biological features of the common NKG2D-ligand allele MICA*008. , 2013, The Biochemical journal.

[56]  T. Beddoe,et al.  Targeting of a natural killer cell receptor family by a viral immunoevasin , 2013, Nature Immunology.

[57]  S. Jonjić,et al.  The evolutionary arms race between NK cells and viruses: Who gets the short end of the stick? , 2013, European journal of immunology.

[58]  S. Gasser,et al.  Regulation of ligands for the NKG2D activating receptor. , 2013, Annual review of immunology.

[59]  Matthew G. Macauley,et al.  Human Cytomegalovirus Glycoprotein UL141 Targets the TRAIL Death Receptors to Thwart Host Innate Antiviral Defenses , 2013, Cell host & microbe.

[60]  C. Benedict,et al.  Structure of Human Cytomegalovirus UL141 Binding to TRAIL-R2 Reveals Novel, Non-canonical Death Receptor Interactions , 2013, PLoS pathogens.

[61]  J. Rossjohn,et al.  Polymorphism in Human Cytomegalovirus UL40 Impacts on Recognition of Human Leukocyte Antigen-E (HLA-E) by Natural Killer Cells* , 2013, The Journal of Biological Chemistry.

[62]  V. Emery,et al.  The “Silent” Global Burden of Congenital Cytomegalovirus , 2013, Clinical Microbiology Reviews.

[63]  A. McWhorter,et al.  Natural Killer Cell Dependent Within-Host Competition Arises during Multiple MCMV Infection: Consequences for Viral Transmission and Evolution , 2013, PLoS pathogens.

[64]  M. Cortese,et al.  Recombinant Human Cytomegalovirus (HCMV) RL13 Binds Human Immunoglobulin G Fc , 2012, PloS one.

[65]  D. Margulies,et al.  Structural basis of mouse cytomegalovirus m152/gp40 interaction with RAE1γ reveals a paradigm for MHC/MHC interaction in immune evasion , 2012, Proceedings of the National Academy of Sciences.

[66]  Jianping Yin,et al.  Structure of TIGIT immunoreceptor bound to poliovirus receptor reveals a cell–cell adhesion and signaling mechanism that requires cis-trans receptor clustering , 2012, Proceedings of the National Academy of Sciences.

[67]  T. Beddoe,et al.  Killer cell immunoglobulin-like receptor 3DL1-mediated recognition of human leukocyte antigen B , 2011, Nature.

[68]  S. Jonjić,et al.  All is fair in virus-host interactions: NK cells and cytomegalovirus. , 2011, Trends in molecular medicine.

[69]  A. Angulo,et al.  Natural killer cell‐mediated response to human cytomegalovirus‐infected macrophages is modulated by their functional polarization , 2011, Journal of leukocyte biology.

[70]  D. Margulies,et al.  How the Virus Outsmarts the Host: Function and Structure of Cytomegalovirus MHC-I-Like Molecules in the Evasion of Natural Killer Cell Surveillance , 2011, Journal of biomedicine & biotechnology.

[71]  S. Jonjić,et al.  Distinct MHC class I–dependent NK cell–activating receptors control cytomegalovirus infection in different mouse strains , 2011, The Journal of experimental medicine.

[72]  A. Corbett,et al.  Functional Consequences of Natural Sequence Variation of Murine Cytomegalovirus m157 for Ly49 Receptor Specificity and NK Cell Activation , 2011, The Journal of Immunology.

[73]  S. Jonjić,et al.  Cytomegalovirus immunoevasin reveals the physiological role of “missing self” recognition in natural killer cell dependent virus control in vivo , 2010, The Journal of experimental medicine.

[74]  P. Tomasec,et al.  Reconstruction of the complete human cytomegalovirus genome in a BAC reveals RL13 to be a potent inhibitor of replication. , 2010, The Journal of clinical investigation.

[75]  H. Ploegh,et al.  The HCMV membrane glycoprotein US10 selectively targets HLA-G for degradation , 2010, The Journal of experimental medicine.

[76]  P. Tomasec,et al.  Human cytomegalovirus UL141 promotes efficient downregulation of the natural killer cell activating ligand CD112 , 2010, The Journal of general virology.

[77]  M. Cannon,et al.  Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection , 2010, Reviews in medical virology.

[78]  M. Smyth,et al.  Innate immunity defines the capacity of antiviral T cells to limit persistent infection , 2010, The Journal of experimental medicine.

[79]  D. Margulies,et al.  Direct interaction of the mouse cytomegalovirus m152/gp40 immunoevasin with RAE-1 isoforms. , 2010, Biochemistry.

[80]  L. Lanier,et al.  “Unlicensed” Natural Killer cells dominate the response to cytomegalovirus infection , 2010, Nature Immunology.

[81]  W. Britt,et al.  Cytomegalovirus reinfections in healthy seroimmune women. , 2010, The Journal of infectious diseases.

[82]  T. Stehle,et al.  Structure of the HCMV UL16-MICB Complex Elucidates Select Binding of a Viral Immunoevasin to Diverse NKG2D Ligands , 2010, PLoS pathogens.

[83]  Mair E. M. Thomas,et al.  NKG2D Ligand MICA Is Retained in the cis-Golgi Apparatus by Human Cytomegalovirus Protein UL142 , 2009, Journal of Virology.

[84]  J. Arapović,et al.  Differential Susceptibility of RAE-1 Isoforms to Mouse Cytomegalovirus , 2009, Journal of Virology.

[85]  S. Jonjić,et al.  Ly49P recognition of cytomegalovirus-infected cells expressing H2-Dk and CMV-encoded m04 correlates with the NK cell antiviral response , 2009, The Journal of experimental medicine.

[86]  J. Fallon,et al.  Enhanced oncolytic potency of vesicular stomatitis virus through vector-mediated inhibition of NK and NKT cells , 2009, Cancer Gene Therapy.

[87]  Joseph C. Sun,et al.  Adaptive Immune Features of Natural Killer Cells , 2009, Nature.

[88]  K. Früh,et al.  Signal Peptide-Dependent Inhibition of MHC Class I Heavy Chain Translation by Rhesus Cytomegalovirus , 2008, PLoS pathogens.

[89]  Y. Jun,et al.  Human Cytomegalovirus UL18 Utilizes US6 for Evading the NK and T-Cell Responses , 2008, PLoS pathogens.

[90]  P. Bjorkman,et al.  Structure of UL18, a peptide-binding viral MHC mimic, bound to a host inhibitory receptor , 2008, Proceedings of the National Academy of Sciences.

[91]  L. M. Smith,et al.  Laboratory Strains of Murine Cytomegalovirus Are Genetically Similar to but Phenotypically Distinct from Wild Strains of Virus , 2008, Journal of Virology.

[92]  T. Beddoe,et al.  CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence , 2008, The Journal of experimental medicine.

[93]  S. Jonjić,et al.  Immune evasion of natural killer cells by viruses. , 2008, Current opinion in immunology.

[94]  D. Lilleri,et al.  Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection , 2008, Haematologica.

[95]  P. Bjorkman,et al.  The Human Cytomegalovirus Fc Receptor gp68 Binds the Fc CH2-CH3 Interface of Immunoglobulin G , 2008, Journal of Virology.

[96]  T. Shenk,et al.  Human cytomegalovirus genome. , 2008, Current topics in microbiology and immunology.

[97]  K. Früh,et al.  Rhesus CMV: an emerging animal model for human CMV , 2008, Medical Microbiology and Immunology.

[98]  D. Heiss-Czedik,et al.  Analysis of the variability of CMV strains in the RL11D domain of the RL11 multigene family , 2007, Virus Genes.

[99]  Hanah Margalit,et al.  Host Immune System Gene Targeting by a Viral miRNA , 2007, Science.

[100]  Todd A Fehniger,et al.  Acquisition of murine NK cell cytotoxicity requires the translation of a pre-existing pool of granzyme B and perforin mRNAs. , 2007, Immunity.

[101]  K. Christopher Garcia,et al.  Structural elucidation of the m157 mouse cytomegalovirus ligand for Ly49 natural killer cell receptors , 2007, Proceedings of the National Academy of Sciences.

[102]  Peter Chen,et al.  Cytomegalovirus evasion of innate immunity by subversion of the NKR-P1B:Clr-b missing-self axis. , 2007, Immunity.

[103]  P. Tomasec,et al.  The Human Cytomegalovirus MHC Class I Homolog UL18 Inhibits LIR-1+ but Activates LIR-1− NK Cells1 , 2007, The Journal of Immunology.

[104]  A. Corbett,et al.  Extensive sequence variation exists among isolates of murine cytomegalovirus within members of the m02 family of genes. , 2007, The Journal of general virology.

[105]  M. Degli-Esposti,et al.  The interplay between host and viral factors in shaping the outcome of cytomegalovirus infection , 2007, Immunology and cell biology.

[106]  H. Šimić,et al.  The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60 , 2006, The Journal of experimental medicine.

[107]  D. Cosman,et al.  Down-regulation of the NKG2D ligand MICA by the human cytomegalovirus glycoprotein UL142. , 2006, Biochemical and biophysical research communications.

[108]  A. Angulo,et al.  Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts. , 2006, Blood.

[109]  L. K. Ely,et al.  Structural basis for a major histocompatibility complex class Ib–restricted T cell response , 2006, Nature Immunology.

[110]  C. Craddock,et al.  Donor KIR genotype has a major influence on the rate of cytomegalovirus reactivation following T-cell replete stem cell transplantation. , 2005, Blood.

[111]  Eunkyung Kim,et al.  Functional dissection of HCMV US11 in mediating the degradation of MHC class I molecules. , 2005, Biochemical and biophysical research communications.

[112]  L. Lanier,et al.  Epistasis between mouse Klra and major histocompatibility complex class I loci is associated with a new mechanism of natural killer cell–mediated innate resistance to cytomegalovirus infection , 2005, Nature Genetics.

[113]  Ofer Levi,et al.  Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus , 2005, Nature Immunology.

[114]  K. Früh,et al.  Rhesus Cytomegalovirus Contains Functional Homologues of US2, US3, US6, and US11 , 2005, Journal of Virology.

[115]  P. Parham,et al.  Natural selection drives recurrent formation of activating killer cell immunoglobulin-like receptor and Ly49 from inhibitory homologues , 2005, The Journal of experimental medicine.

[116]  S. Jonjić,et al.  Selective Down-Regulation of the NKG2D Ligand H60 by Mouse Cytomegalovirus m155 Glycoprotein , 2005, Journal of Virology.

[117]  P. Tomasec,et al.  Downregulation of natural killer cell–activating ligand CD155 by human cytomegalovirus UL141 , 2005, Nature Immunology.

[118]  D. Busch,et al.  NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145 , 2004, The Journal of experimental medicine.

[119]  G. Trinchieri,et al.  Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity , 2005, Nature Immunology.

[120]  J. Geelen,et al.  Initial characterization of four cytomegalovirus strains isolated from chimpanzees , 2005, Archives of Virology.

[121]  L. Lanier,et al.  The Cytomegalovirus m155 Gene Product Subverts Natural Killer Cell Antiviral Protection by Disruption of H60–NKG2D Interactions , 2004, The Journal of experimental medicine.

[122]  Alexandra Lucas,et al.  Secreted Immunomodulatory Viral Proteins as Novel Biotherapeutics12 , 2004, The Journal of Immunology.

[123]  Salim I. Khakoo,et al.  HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection , 2004, Science.

[124]  A. Varin,et al.  Mixed cytomegalovirus glycoprotein B genotypes in immunocompromised patients. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[125]  H. Ploegh,et al.  A membrane protein required for dislocation of misfolded proteins from the ER , 2004, Nature.

[126]  S. Jonjić,et al.  Escape of mutant double-stranded DNA virus from innate immune control. , 2004, Immunity.

[127]  Lewis L Lanier,et al.  Functional characterization of DNAM-1 (CD226) interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/CD112). , 2004, International immunology.

[128]  R. Kroczek,et al.  Coordinate Expression of Cytokines and Chemokines by NK Cells during Murine Cytomegalovirus Infection1 , 2004, The Journal of Immunology.

[129]  C. Ahn,et al.  Human cytomegalovirus UL18 alleviated human NK-mediated swine endothelial cell lysis. , 2004, Biochemical and biophysical research communications.

[130]  K. Früh,et al.  Human cytomegalovirus inhibits tapasin-dependent peptide loading and optimization of the MHC class I peptide cargo for immune evasion. , 2004, Immunity.

[131]  V. Štolc,et al.  Functional profiling of a human cytomegalovirus genome , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[132]  M. Degli-Esposti,et al.  Murine cytomegalovirus m157 mutation and variation leads to immune evasion of natural killer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[133]  Mitchell Kronenberg,et al.  Constitutive Cytokine mRNAs Mark Natural Killer (NK) and NK T Cells Poised for Rapid Effector Function , 2003, The Journal of experimental medicine.

[134]  A. Angulo,et al.  Differential effects of US2, US6 and US11 human cytomegalovirus proteins on HLA class Ia and HLA‐E expression: impact on target susceptibility to NK cell subsets , 2003, European journal of immunology.

[135]  L. Moretta,et al.  Identification of PVR (CD155) and Nectin-2 (CD112) as Cell Surface Ligands for the Human DNAM-1 (CD226) Activating Molecule , 2003, The Journal of experimental medicine.

[136]  C. Sutherland,et al.  Human Cytomegalovirus Glycoprotein UL16 Causes Intracellular Sequestration of NKG2D Ligands, Protecting Against Natural Killer Cell Cytotoxicity , 2003, The Journal of experimental medicine.

[137]  L. Lanier,et al.  NKG2D-mediated Natural Killer Cell Protection Against Cytomegalovirus Is Impaired by Viral gp40 Modulation of Retinoic Acid Early Inducible 1 Gene Molecules , 2003, The Journal of experimental medicine.

[138]  E. Remmerswaal,et al.  Primary immune responses to human CMV: a critical role for IFN-gamma-producing CD4+ T cells in protection against CMV disease. , 2003, Blood.

[139]  J. Yewdell,et al.  A single viral protein HCMV US2 affects antigen presentation and intracellular iron homeostasis by degradation of classical HLA class I and HFE molecules. , 2003, Blood.

[140]  P. Griffiths,et al.  Homology between the human cytomegalovirus RL11 gene family and human adenovirus E3 genes. , 2003, The Journal of general virology.

[141]  M. Smyth,et al.  Functional interactions between dendritic cells and NK cells during viral infection , 2003, Nature Immunology.

[142]  H. Ploegh,et al.  The Human Cytomegalovirus US10 Gene Product Delays Trafficking of Major Histocompatibility Complex Class I Molecules , 2002, Journal of Virology.

[143]  M. Reddehase.  Antigens and immunoevasins: opponents in cytomegalovirus immune surveillance , 2002, Nature Reviews Immunology.

[144]  D. Fremont,et al.  Recognition of a virus-encoded ligand by a natural killer cell activation receptor , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[145]  P. Tomasec,et al.  UL40-mediated NK evasion during productive infection with human cytomegalovirus , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[146]  L. Lanier,et al.  Direct Recognition of Cytomegalovirus by Activating and Inhibitory NK Cell Receptors , 2002, Science.

[147]  Y. Sung,et al.  The MHC Class I Homolog of Human Cytomegalovirus Is Resistant to Down-Regulation Mediated by the Unique Short Region Protein (US)2, US3, US6, and US11 Gene Products1 , 2002, The Journal of Immunology.

[148]  H. Ploegh,et al.  Membrane-specific, Host-derived Factors Are Required for US2- and US11-mediated Degradation of Major Histocompatibility Complex Class I Molecules* , 2002, The Journal of Biological Chemistry.

[149]  B. Lavingia,et al.  MICA polymorphism in South American Indians , 2002, Immunogenetics.

[150]  M. Messerle,et al.  Identification and expression of human cytomegalovirus transcription units coding for two distinct Fcgamma receptor homologs. , 2002, Journal of virology.

[151]  G. McDermott,et al.  Crystal structures of RAE-1beta and its complex with the activating immunoreceptor NKG2D. , 2002, Immunity.

[152]  W. Tian,et al.  MICA genetic polymorphism and linkage disequilibrium with HLA-B in 29 African-American families , 2001, Immunogenetics.

[153]  P. Sun,et al.  Conformational plasticity revealed by the cocrystal structure of NKG2D and its class I MHC-like ligand ULBP3. , 2001, Immunity.

[154]  H. Ploegh,et al.  Human Cytomegalovirus Open Reading Frame TRL11/IRL11 Encodes an Immunoglobulin G Fc-Binding Protein , 2001, Journal of Virology.

[155]  J. Yewdell,et al.  Human Cytomegalovirus Protein US2 Interferes with the Expression of Human HFE, a Nonclassical Class I Major Histocompatibility Complex Molecule That Regulates Iron Homeostasis , 2001, Journal of Virology.

[156]  H. Inoko,et al.  Diversity of MICA (PERB11.1) and HLA haplotypes in Northeastern Thais. , 2001, Tissue antigens.

[157]  D. Wiley,et al.  Antigen presentation subverted: Structure of the human cytomegalovirus protein US2 bound to the class I molecule HLA-A2 , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[158]  R. Strong,et al.  Complex structure of the activating immunoreceptor NKG2D and its MHC class I–like ligand MICA , 2001, Nature Immunology.

[159]  P. Lehner,et al.  The human cytomegalovirus gene product US6 inhibits ATP binding by TAP , 2001, The EMBO journal.

[160]  G. Sandford,et al.  Identification and Characterization of a Spliced C-Type Lectin-Like Gene Encoded by Rat Cytomegalovirus , 2001, Journal of Virology.

[161]  C. Bruggeman,et al.  Complete DNA Sequence of the Rat Cytomegalovirus Genome , 2000, Journal of Virology.

[162]  J. Ellwart,et al.  Cutting Edge: The Human Cytomegalovirus UL40 Gene Product Contains a Ligand for HLA-E and Prevents NK Cell-Mediated Lysis1 , 2000, The Journal of Immunology.

[163]  E. Kremmer,et al.  The luminal part of the murine cytomegalovirus glycoprotein gp40 catalyzes the retention of MHC class I molecules , 2000, The EMBO journal.

[164]  A. McMichael,et al.  Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. , 2000, Science.

[165]  K. Früh,et al.  A role for MHC class I down‐regulation in NK cell lysis of herpes virus‐infected cells , 2000, European journal of immunology.

[166]  P. Bjorkman,et al.  The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18. , 1999, Immunity.

[167]  P. Cresswell,et al.  Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4+ T cells , 1999, Nature Medicine.

[168]  J. Yewdell,et al.  Cutting edge: adenovirus E19 has two mechanisms for affecting class I MHC expression. , 1999, Journal of immunology.

[169]  U. Koszinowski,et al.  A cytomegalovirus glycoprotein re‐routes MHC class I complexes to lysosomes for degradation , 1999, The EMBO journal.

[170]  C. Biron,et al.  Natural killer cells in antiviral defense: function and regulation by innate cytokines. , 1999, Annual review of immunology.

[171]  P. Bjorkman,et al.  Modulation of Natural Killer Cell Cytotoxicity in Human Cytomegalovirus Infection: The Role of Endogenous Class I Major Histocompatibility Complex and a Viral Class I Homolog , 1998, The Journal of experimental medicine.

[172]  S. Jonjić,et al.  Virus Attenuation after Deletion of the Cytomegalovirus Fc Receptor Gene Is Not due to Antibody Control , 1998, Journal of Virology.

[173]  P. Cresswell,et al.  The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[174]  A. McMichael,et al.  The human major histocompatibility complex class Ib molecule HLA‐E binds signal sequence‐derived peptides with primary anchor residues at positions 2 and 9 , 1997, European journal of immunology.

[175]  P. A. Peterson,et al.  The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. , 1997, Immunity.

[176]  O. Mandelboim,et al.  The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells , 1997, Nature.

[177]  M. Yamazaki,et al.  Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Behçet disease. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[178]  H. Ploegh,et al.  A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface , 1997, The EMBO journal.

[179]  U. Koszinowski,et al.  A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments. , 1997, Immunity.

[180]  T. Rapoport,et al.  Sec6l-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction , 1996, Nature.

[181]  B. Barrell,et al.  Analysis of the complete DNA sequence of murine cytomegalovirus , 1996, Journal of virology.

[182]  H. Ploegh,et al.  Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[183]  T. Mcclanahan,et al.  DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes. , 1996, Immunity.

[184]  M. Bogyo,et al.  The Human Cytomegalovirus US11 Gene Product Dislocates MHC Class I Heavy Chains from the Endoplasmic Reticulum to the Cytosol , 1996, Cell.

[185]  E Tom,et al.  Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains , 1996, Journal of virology.

[186]  William Arbuthnot Sir Lane,et al.  The MHC class I homolog encoded by human cytomegalovirus binds endogenous peptides. , 1995, Immunity.

[187]  S. Riddell,et al.  Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. , 1995, The New England journal of medicine.

[188]  L. Sun,et al.  Multiple independent loci within the human cytomegalovirus unique short region down-regulate expression of major histocompatibility complex class I heavy chains , 1995, Journal of virology.

[189]  U. Koszinowski,et al.  Identification and expression of a murine cytomegalovirus early gene coding for an Fc receptor , 1994, Journal of virology.

[190]  G. Trinchieri,et al.  Identification of a novel signal transduction surface molecule on human cytotoxic lymphocytes , 1993, The Journal of experimental medicine.

[191]  S. Riddell,et al.  Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. , 1991, Blood.

[192]  S. Jonjić,et al.  Efficacious control of cytomegalovirus infection after long-term depletion of CD8+ T lymphocytes , 1990, Journal of virology.

[193]  S. Beck,et al.  A complex between the MHC class I homologue encoded by human cytomegalovirus and β2 microglobulin , 1990, Nature.

[194]  J. Yewdell,et al.  Antigen presentation requires transport of MHC class I molecules from the endoplasmic reticulum. , 1990, Science.

[195]  S. Beck,et al.  Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens , 1988, Nature.

[196]  C Tuffnell,et al.  Taking the strain. , 1987, The New Zealand nursing journal. Kai tiaki.

[197]  H. Ljunggren,et al.  Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy , 1986, Nature.

[198]  J. Manischewitz,et al.  Cytotoxic t cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients. , 1982, The New England journal of medicine.

[199]  S. Plotkin,et al.  Demonstration of immunoglobulin G receptors induced by human cytomegalovirus , 1975, Journal of clinical microbiology.